Botanical species · safety record

Seidlitzia rosmarinus

The EFSA Compendium of Botanicals holds 1 adverse-effect record for Seidlitzia rosmarinus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Seidlitzia rosmarinus Bunge ex Boiss.

0Constituent measurements
1Safety records
1Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Plant parts

  • Bud1

Preparations

  • Fresh1

Effect types

  • Systemic1

Target tissues

  • Urogenital: kidneys1

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicUrogenital: kidneysBudFreshSheep (as animal)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Aslani, Mohammad Reza., Movassaghi, Ahmad Reza., Najarnezhad, Vahid., Pirouz, Hossein Janati., Bami, Mohammad Heidarpour. Acute oxalate intoxication associated to ingestion of eshnan (Seidlitzia rosmarinus) in sheep. TROPICAL ANIMAL HEALTH AND PRODUCTION, 2011, vol. 43, no. 6, p. 1065-1068. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue